Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Insights, Forecast to 2028
SKU ID : QYR-20465242 | Publishing Date : 10-Mar-2022
Detailed TOC of Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Insights, Forecast to 2028
1 Report Business Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Perspective (2017-2028)
2.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Growth Trends by Region
2.2.1 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Region (2017-2022)
2.2.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Region (2023-2028)
2.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Dynamics
2.3.1 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Industry Trends
2.3.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Drivers
2.3.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Challenges
2.3.4 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Revenue
3.1.1 Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Revenue (2017-2022)
3.1.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue
3.4 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Concentration Ratio
3.4.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue in 2021
3.5 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Key Players Head office and Area Served
3.6 Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Solution and Service
3.7 Date of Enter into B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Breakdown Data by Type
4.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Type (2017-2022)
4.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Type (2023-2028)
5 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Breakdown Data by Application
5.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Application (2017-2022)
5.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2017-2028)
6.2 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type
6.2.1 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022)
6.2.2 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028)
6.2.3 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type (2017-2028)
6.3 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application
6.3.1 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022)
6.3.2 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028)
6.3.3 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application (2017-2028)
6.4 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country
6.4.1 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022)
6.4.2 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2017-2028)
7.2 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type
7.2.1 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022)
7.2.2 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028)
7.2.3 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type (2017-2028)
7.3 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application
7.3.1 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022)
7.3.2 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028)
7.3.3 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application (2017-2028)
7.4 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country
7.4.1 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022)
7.4.2 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2017-2028)
8.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type
8.2.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application
8.3.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region
8.4.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2017-2028)
9.2 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type
9.2.1 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022)
9.2.2 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028)
9.2.3 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type (2017-2028)
9.3 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application
9.3.1 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022)
9.3.2 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028)
9.3.3 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application (2017-2028)
9.4 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country
9.4.1 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022)
9.4.2 Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2017-2028)
10.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type
10.2.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application
10.3.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country
10.4.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.1.4 Amgen Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
11.1.5 Amgen Recent Developments
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.2.4 Bayer Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
11.2.5 Bayer Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Merck Serono
11.4.1 Merck Serono Company Details
11.4.2 Merck Serono Business Overview
11.4.3 Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.4.4 Merck Serono Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
11.4.5 Merck Serono Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.5.4 Roche Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
11.5.5 Roche Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.6.4 AstraZeneca Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
11.6.5 AstraZeneca Recent Developments
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.7.4 AbbVie Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
11.7.5 AbbVie Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
11.8.4 Novartis Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
11.8.5 Novartis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Figures, Tables and Charts Available in Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Insights, Forecast to 2028
List of TablesTable 1. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Others
Table 5. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region (2017-2022)
Table 9. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region (2023-2028)
Table 11. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Trends
Table 12. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Drivers
Table 13. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Challenges
Table 14. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Restraints
Table 15. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment as of 2021)
Table 18. Ranking of Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Solution and Service
Table 22. Date of Enter into B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Application (2017-2022)
Table 30. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Application (2023-2028)
Table 32. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. Amgen Company Details
Table 63. Amgen Business Overview
Table 64. Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 65. Amgen Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million)
Table 66. Amgen Recent Developments
Table 67. Bayer Company Details
Table 68. Bayer Business Overview
Table 69. Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 70. Bayer Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million)
Table 71. Bayer Recent Developments
Table 72. Bristol-Myers Squibb Company Details
Table 73. Bristol-Myers Squibb Business Overview
Table 74. Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 75. Bristol-Myers Squibb Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million)
Table 76. Bristol-Myers Squibb Recent Developments
Table 77. Merck Serono Company Details
Table 78. Merck Serono Business Overview
Table 79. Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 80. Merck Serono Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million)
Table 81. Merck Serono Recent Developments
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 85. Roche Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million)
Table 86. Roche Recent Developments
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 90. AstraZeneca Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million)
Table 91. AstraZeneca Recent Developments
Table 92. AbbVie Company Details
Table 93. AbbVie Business Overview
Table 94. AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 95. AbbVie Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million)
Table 96. AbbVie Recent Developments
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product
Table 100. Novartis Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022) & (US$ Million)
Table 101. Novartis Recent Developments
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Type: 2021 VS 2028
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Others Features
Figure 5. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Report Years Considered
Figure 11. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Players in 2021
Figure 15. Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue in 2021
Figure 17. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Type (2017-2028)
Figure 19. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Application (2017-2028)
Figure 20. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by Country (2017-2028)
Figure 21. United States B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Type (2017-2028)
Figure 25. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Application (2017-2028)
Figure 26. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by Country (2017-2028)
Figure 27. Germany B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by Region (2017-2028)
Figure 37. China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Type (2017-2028)
Figure 45. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Application (2017-2028)
Figure 46. Latin America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by Country (2017-2028)
Figure 47. Mexico B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by Country (2017-2028)
Figure 53. Turkey B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Amgen Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
Figure 57. Bayer Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
Figure 59. Merck Serono Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
Figure 61. AstraZeneca Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
Figure 62. AbbVie Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
Figure 63. Novartis Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Keyplayers in Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Insights, Forecast to 2028
AmgenBayer
Bristol-Myers Squibb
Merck Serono
Roche
AstraZeneca
AbbVie
Novartis